Loading clinical trials...
Loading clinical trials...
The purpose of this clinical trial is to evaluate whether using pharmacogenetic testing to guide antidepressant treatment can improve outcomes in adults with major depressive disorder in Morocco. Depr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mohammed V University in Rabat
Collaborators
NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more
NCT06878859 · Depression - Major Depressive Disorder, Cannabis Use Disorder, and more
NCT07422519 · Depression - Major Depressive Disorder, Depression Disorder, and more
NCT07424781 · Depression - Major Depressive Disorder, Irritability, and more
NCT07404085 · Bipolar Disorder (BD), Depression - Major Depressive Disorder, and more
Ar-Razi Psychiatric Hospital, Ibn Sina University Hospital
Rabat, Rabat-Salé-Kénitra
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions